Beryl Drugs Share Price
23.69+0.48 (+2.07%)
+3.72% past 1 Year
Corporate filings & documents
Announcements
NEWSPAPER PUBLICATION OF 33RD ANNUAL GENERAL MEETING NOTICE
2 weeks agoANNUAL REPORT 2025-2026
2 weeks agoANNUAL REPORT 2025-2026
2 weeks ago33RD ANNUAL GENERAL MEETING NOTICE
2 weeks ago33RD ANNUAL GENERAL MEETING NOTICE
2 weeks agoEVOTING DATES FOR THE PURPOSE OF 33RD ANNUAL GENERAL MEETING
2 weeks agoRECORD DATE
2 weeks agoINTIMATION OF ANNUAL BOOK CLOSURE
2 weeks agoOUTCOME OF BOARD MEETING
2 weeks agoOUTCOME OF BOARD MEETING
2 weeks agoBeryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2026 inter alia to consider and approve approve board report and other matters related to 33rd annual general meeting of the company
3 weeks agoBeryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2026 inter alia to consider and approve approve board report and other matters related to 33rd annual general meeting of the company
3 weeks agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
1 month agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
1 month agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
1 month agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
1 month agoNEWSPAPER PUBLICATION OF UNAUDITED QUARTERLY FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2026
1 month agoNEWSPAPER PUBLICATION OF UNAUDITED QUARTERLY FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2026
1 month agoUNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2026
1 month agoUNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2026
1 month agoOUTCOME OF BOARD MEETING
1 month agoOUTCOME OF BOARD MEETING
1 month agoBeryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve the unaudited financial results for the quarter ended 30th june 2026
1 month agoBeryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve the unaudited financial results for the quarter ended 30th june 2026
1 month agoTEMPORARY UNAVAILABILITY OF THE COMPANYS WEBSITE "www.beryldrugs.com" DUE TO AN UNEXPECTED TECHNICAL ISSUE.
2 months agoTEMPORARY UNAVAILABILITY OF THE COMPANYS WEBSITE "www.beryldrugs.com" DUE TO AN UNEXPECTED TECHNICAL ISSUE.
2 months agoCERTIFICATE UNDER REGULATION 74(5) OF SEBI (DP) REGULATIONS 2018
2 months agoCERTIFICATE UNDER REGULATION 74(5) OF SEBI (DP) REGULATIONS 2018
2 months agoNON-APPLOCABILITY CERTIFICATE UNDER REGULATION 57(5) FOR THE QUARTER ENDED 30TH JUNE 2026
2 months agoNON-APPLOCABILITY CERTIFICATE UNDER REGULATION 57(5) FOR THE QUARTER ENDED 30TH JUNE 2026
2 months agoCLOSURE OF TRADING WINDOW FOR THE QUARTER ENDED 30.06.2026
2 months agoCLOSURE OF TRADING WINDOW FOR THE QUARTER ENDED 30.06.2026
2 months agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
2 months agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
2 months agoCHANGE IN REGISTERED OFFICE OF THE COMPANY FROM 133 KANCHAN BAGH INDORE TO 29 NEER NAGAR MAYANK WATER PARK ROAD BICHOLI INDORE WITHIN LOCAL LIMITS OF SAME CITY
3 months agoCHANGE IN REGISTERED OFFICE OF THE COMPANY FROM 133 KANCHAN BAGH INDORE TO 29 NEER NAGAR MAYANK WATER PARK ROAD BICHOLI INDORE WITHIN LOCAL LIMITS OF SAME CITY
3 months agoOUTCOME OF BOARD MEETING
3 months agoOUTCOME OF BOARD MEETING
3 months agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
3 months agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
3 months agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
3 months agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
3 months agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
3 months agoBeryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/06/2026 inter alia to consider and approve change in registered office of the company within local limits of the same city
3 months agoBeryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/06/2026 inter alia to consider and approve change in registered office of the company within local limits of the same city
3 months agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
3 months agoNEWSPAPER PUBLICATION OF AUDITED FINANCIAL RESULTS FOR THE YEAR ENDED 31ST MARCH 2026
3 months agoNEWSPAPER PUBLICATION OF AUDITED FINANCIAL RESULTS FOR THE YEAR ENDED 31ST MARCH 2026
3 months agoAUDITED FINANCIAL RESULTS FOR THE YEAR ENDED 31ST MARCH 2026
3 months agoOUTCOME OF BOARD MEETING
3 months agoAnnual reports
Concalls & investor presentations
No presentations found